Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
2992 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 22 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2732 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-02-23 | 2024-03-22 | 220459 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-02-23 | 2024-03-29 | 220456 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-02-23 | 2024-03-01 | 220453 |
| APO-FLUOXETINE | 10MG | CAPSULE | Resolved | 2024-02-23 | 2024-03-01 | 220450 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-02-23 | 2024-03-22 | 220447 |
| APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Resolved | 2024-02-23 | 2024-03-01 | 220444 |
| APO-DONEPEZIL | 10MG | TABLET | Actual shortage | 2024-02-23 | 2024-04-05 | 220441 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Actual shortage | 2024-02-16 | 2024-03-27 | 219843 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-02-16 | 2024-04-05 | 219840 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-02-16 | 2024-03-08 | 219837 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2024-02-16 | 2024-03-29 | 219834 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-02-09 | 2024-04-12 | 219180 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-02-09 | 2024-04-12 | 219177 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-02-09 | 2024-03-15 | 219174 |
| APO-NAPROXEN | 500MG | TABLET | Actual shortage | 2024-02-09 | 2024-04-05 | 219171 |
| APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2024-02-09 | 2024-02-16 | 219168 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2024-02-09 | 2024-03-29 | 219165 |
| APO-MIDODRINE | 2.5MG | TABLET | Actual shortage | 2024-02-09 | 2024-03-22 | 219162 |
| APO-OXCARBAZEPINE | 150MG | TABLET | Actual shortage | 2024-02-09 | 2024-04-12 | 219159 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2024-02-09 | 2024-03-08 | 219156 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-NITRAZEPAM | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |
| APO-NITRAZEPAM | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
| APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
| APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
| APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
| APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
| APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
| APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |